SEC Form 5 · accession 0001209191-15-010310
Conatus Pharmaceuticals Inc. · CNAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Cashion
Officer — SVP, Finance, CFO and Sec.
Period of report
Dec 31, 2014
Accepted (ET)
Feb 6, 2015 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001383701
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 2, 2014 | G | 5,000 | $0.00 | D | 144,738 | I | See footnote. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Held in a trust of which Mr. Cashion is a trustee.